版本:
中国

BRIEF-Paratek announces completion of enrollment for oral-only omadacycline phase 3 skin study

May 8 Paratek Pharmaceuticals Inc

* Paratek announces completion of enrollment for oral-only omadacycline phase 3 skin study, top-line data expected in mid-july Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐